DGAP-News: Biogenic Reagents Begins Commercial Production

New Post Public Reply Private Reply Replies (0) Message Board

News Desk 2018

Aug 5, 2013 at 9:15 AM

DGAP-News: Biogenic Reagents Begins Commercial Production of New Ultra-Adsorptive Graphene-Carbon Compounds From Renewable Sources

Biogenic 05.08.2013 15:00 --------------------------------------------------------------------------- Better Able to Purify Air and Water and Outperform Traditional Activated Carbons Made From Coal MINNEAPOLIS, 2013-08-05 15:00 CEST (GLOBE NEWSWIRE) -- Biogenic Reagents ('Biogenic'), a leading manufacturer of high-performance carbon and producer of over a half dozen leading-edge patent-pending carbon technologies, today announced it has begun commercial production of new Ultra-Adsorptive Carbon ('UAC') products. UAC products are made from renewable biomass, outperform existing coal-based products and are expected to displace the use of traditional activated carbon products for air and water purification. Biogenic will manufacture UACs at its state-of-the-art Marquette, Michigan facility, which is the largest advanced biocarbon production facility in the United States. The innovative facility uses renewable energy and has the smallest environmental impact per unit of production of any activated carbon producer in the world. Activated carbon is commonly made from coal and is processed to create a highly porous material for use in removing impurities from liquids and gases. Biogenic's new commercial process produces a graphene-carbon compound from a wood feedstock that has approximately 50% greater adsorptive capacity than typical coal-based activated carbon products available in the market today, according to laboratory testing. James Mennell, Chief Executive Officer of Biogenic, said, 'Biogenic is a pioneer in low cost, high-performance carbon products that conserve and improve air and water quality and the environment. We are excited to introduce our new Ultra-Adsorptive Carbon products for a wide range of customers and uses. Most graphene produced today is made from fossil fuels and is produced in very small amounts. Our new UAC products can be produced on a commercial scale and are proven to better purify food, water and air than current activated carbon and will enhance the lives of end-consumers on a global basis. At Biogenic, we don't waste water, we purify it.' Dan Despen, Biogenic's Chief Technology Officer, said, 'Graphene is considered a 'material of the future,' and at Biogenic, we are producing and using it today. Our UACs have greater adsorptive capacity than products currently in the market, and because of our proprietary process and inexpensive feedstock, our company can produce the UACs for less than the cost of coal-based products. Importantly, unlike other major producers of activated carbon that use and discharge millions of gallons of water each year, production of Biogenic's new graphene-carbon products does not create any wastewater.' Mennell added, 'In addition to the financial backing from our partner, MVC Capital, Inc., which we recently closed on, we plan on expanding our Michigan production facility and will be better positioned to develop and commercialize new environmental technologies that will reduce our customers' costs and benefit the environment.' About Biogenic Reagents Biogenic Reagents is a developer and producer of versatile, high-performance carbon products made from renewable resources. The company offers less expensive, higher-performing and cleaner alternatives to traditional coal-based carbon products. Privately held, Biogenic Reagents is headquartered in Minnesota with a production facility in Michigan. More information about Biogenic can be found at www.biogenicreagents.com. CONTACT: Biogenic Reagent - James A. Mennell 612-599-5951 News Source: NASDAQ OMX 05.08.2013 Dissemination of a Corporate News, transmitted by DGAP - a company of EQS Group AG. The issuer is solely responsible for the content of this announcement. DGAP's Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.dgap-medientreff.de and www.dgap.de --------------------------------------------------------------------------- Language: English Company: Biogenic United States Phone: Fax: E-mail: Internet: ISIN: US9902742769 WKN: End of Announcement DGAP News-Service ---------------------------------------------------------------------------

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Aetna's 2027 Medicare Plans: Comprehensive Outlook

Unpacking Aetna's Medicare Strategy for 2027 Look, if there's one thing you should keep tabs on, it's how Aetna isn't just coasting by in the healthcare arena. These folks are pushing forward with new options for 2027 that prove they're serious about making healthcare not just accessible, but affordable across the board. Aetna, backed by CVS Health (NYSE: CVS), is making...

The Real Cost of Cabinet Decisions: Refinish or Replace?

Uncovering the Truth Behind Cabinet Decisions When it comes to sprucing up a kitchen, most folks overlook what's hanging on their walls already: those tired old cabinets. Now, are you looking at chucking them out the window for brand-new ones, or can a fresh coat of paint breathe new life into them? Well, that's where Melvin Jones, a painting virtuoso from Lexington,...

Vatrer Power: Lithium Batteries Revolutionize Golf Carts

The humdrum world of golf carts just got a jolt of energy with lithium batteries entering the fray. Vatrer Power, the brain behind some nifty LiFePO4 lithium battery conversions, made some noise at this year's Golf Carting Expo & Dealer Summit in Charleston, South Carolina. Held at the North Charleston Convention Center, this trade show was the industry's premier...

Trading Platforms Poised for Billions by 2031

Forecasts and Fierce Digital Landscapes Just when you thought the online trading realm was getting saturated, the numbers are making it clear: there’s still room for growth—even explosive growth. The online trading platform market is eyeing a hike, jumping from a $11.65 billion valuation in 2025 to a projected $18.18 billion by 2031, according to Mordor Intelligence....

Govee Stirs Halloween Chills with New Sarah Gellar Ad

Lighting Up Halloween the Hollywood Way When it comes to Halloween, folks go nuts driving up the thrill factor at home, and boy, has Govee nailed it this time around. They've dragged Sarah Michelle Gellar into their spooky mix, transforming homes into eerie masterpieces. And let's face it, who better than the 'Buffy the Vampire Slayer' herself to stir those spine-tingling...

Venice's Climate Challenge: Rising Seas, Sinking Lands

Sea Rise Isn’t Just a Statistics Problem The ordeal of rising seas isn't just about staring at numbers in some spreadsheet, it's a real-world gut punch that's knocking at Venice's door. This city, known for its stunning architecture and winding canals, now serves as the poster child for what happens when Mother Nature and human errors leave a place on the brink of...

Kal Plastics Showcases at Design-2-Part Expo

Kal Plastics Steps into the Limelight There's a buzz in the air, and it's all about Kal Plastics getting ready to strut their stuff at the Southern California Design-2-Part Show. Now, most folks probably don't spend their nights dreaming about thermoforming and pressure forming, but these guys sure make a case for it. They’ve got their eyes on impressing the crowd with...

Honeywell's Supply Line Snags Bait Class Action Risk

Stepping into the chaos of the stock market sometimes feels like opening Pandora's box—just when you think you've seen it all, something new tumbles out. This time around, it's Honeywell Aerospace (NasdaqGS: HONA) playing catch with hot coals, and a burning class-action lawsuit smolders in the air. Deadline Looms for Investors in Class Action Heads up, folks! If you've...

Ractigen's Breakthrough in DMD: RNA Activates Utrophin

Ractigen's New Fight Against Duchenne: A Personal Take When it comes to biotech advancements, I've seen enough breakthroughs to not get swayed easily. But Ractigen Therapeutics presenting their first-in-human data on RNA activation for Duchenne Muscular Dystrophy (DMD) kind of demands your attention. Folks, they're talking about a potential shift in handling this brutal...